Search Results - Standard Search:"novel coronavirus" OR Covid OR "Sars-CoV" OR "CoV-2" OR ncov

PubPharm (534)

1

COVID-19 cumulative incidence, intensive care, and mortality in Italian regions compared to selected European countries

in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | Vol. 102 (2021), p. 363-368

by Olivieri, A. | Palù, G. | Sebastiani, G.

2

Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients : Is prolonged quarantine always justified?

in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | Vol. 102 (2021), p. 299-302

by Piralla, A. | Ricchi, M. | Cusi, M. | +16

3

Role of favipiravir in the treatment of COVID-19

in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | Vol. 102 (2021), p. 501-508

by Joshi, S. | Parkar, J. | Ansari, A. | +5

4

Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19 : a meta-analysis and insights into pathogenesis

in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | Vol. 102 (2021), p. 319-326

by Zou, H. | Lu, J. | Liu, J. | +6

5

HIV/SARS-CoV-2 co-infection : T cell profile, cytokine dynamics and role of exhausted lymphocytes

in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | Vol. 102 (2021), p. 163-169

by Sharov, K.

6

How useful is serology for COVID-19?

in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | Vol. 102 (2021), p. 170-171

by Raoult, D.

7

Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?

in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | Vol. 102 (2021), p. 389-391

by Çelik, H. | Keske, �. | Şener, �. | +7

8

COVID-19 in the least developed, fragile, and conflict-affected countries - How can the most vulnerable be protected?

in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | Vol. 102 (2021), p. 381-388

by Ebrahim, S. | Gozzer, E. | Ahmed, Y. | +6

9

The art of the possible in approaching efficacy trials for COVID19 convalescent plasma

in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | Vol. 102 (2021), p. 244-246

by Focosi, D. | Farrugia, A.

10

Asymptomatic hypoxia in COVID-19 is associated with poor outcome

in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | Vol. 102 (2021), p. 233-238

by Brouqui, P. | Amrane, S. | Million, M. | +4

1
2
3
4
5
6
7
8
9
10
11
Next »
[54]